Combination antiretroviral therapy has also been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4).
El tratamiento antirretroviral combinado se ha asociado asimismo a alteraciones metabólicas tales como hipertrigliceridemia, hipercolesterolemia, resistencia a la insulina, hiperglucemia e hiperlactemia (ver sección 4.4).